Page 20 - 第22屆新創事業獎得獎專輯
P. 20
科技產業組 Tech Industry Category
U-Neuron Biomedical Inc.
President Fen-Ren, Chien Website https://www.u-neuron.com
Address
18F-5, No.99, Sec.1, Xintai 5th Rd., Established Sep. 4, 2015
Tel Xizhi Dist., New Taipei City 221416, Date
Fax Taiwan
Business Biotechnology services for stem cell
+886 2 2697 5599 Category applications
+886 2 2697 1389 Capital NT$ 295,500,000
Introduction new treatments. With the unique patented
amniotic fluid stem cell technology as the
Established in 2015, U-Neuron Biomedical core capabilities, U-Neuron has developed
Inc. (hereafter referred to as U-Neuron) is two main operational focuses: (1) new drug
devoted to research and development of stem development and (2) cosmetic & healthcare
cell storage & separation technology and consumer products. Stem cell therapy
treatment application technology. U-Neuron drug products are developed from human
holds the patents on amniotic fluid stem cells allogeneic AFSCs and their derivatives, while
(hereafter referred to as AFSCs) and is the first a series of cosmetic and healthcare products
inventor in the world to separate and expand are from amniotic fluid of deer origin.
human AFSCs. To fulfill the unmet medical
needs, we are committed to providing Product advantages and
patients with innovative and effective competitiveness
treatment options through regenerative
medicine. Applying the core R&D capabilities, Amniotic fluid stem cells (hereafter referred
we integrate domestic and foreign resources to as AFSCs) have characteristics close to
to develop products based on allogeneic embryonic stem cells, while without ethical
AFSCs and their derivatives. Medical and conflict or usage limitations. In terms
healthcare solutions to neurological, of cell characteristics, AFSCs have many
inflammatory, degenerative and other related advantages such as rapid growth, more
diseases could be found, allowing patients safety, potent differentiation ability, and
to obtain affordable, safe and effective low immunogenicity, which are also known
1199
